AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.1 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Publishing Language: Chinese | Open Access

Research progress in nanotechnology for the diagnosis and treatment of bronchial asthma

Ziqi Ding, Qian Zhang ( )
Department of Respiratory and Critical Care Medicine, the Third Affiliated Hospital of Nanjing Medical University, Changzhou 213164, China
Show Author Information

Abstract

Bronchial asthma is a common chronic inflammatory airway disease that significantly impacts patients’quality of life. Traditional diagnostic methods for asthma cannot accurately determine its phenotype and genotype, necessitating more advanced non-invasive approaches for diagnosis and assessment. Current asthma treatments primarily rely on glucocorticoids and bronchodilators, but long-term use may lead to adverse effects, drug resistance, and other problems, which makes it particularly important to find new therapeutic approaches. In recent years, nanotechnology has garnered significant attention as an innovative drug delivery platform, capable of substantially enhancing drug bioavailability, targeting efficiency, and therapeutic outcomes. This review summarizes the latest research advances in nanotechnology for bronchial asthma diagnosis and treatment, analyzes its application prospects in asthma diagnosis, and outlines the mechanisms of action of nanocarriers in drug delivery, targeted therapy, and inflammation regulation. Furthermore, it summarizes the potential challenges and future directions for nanotechnology in clinical asthma translation, providing a reference for further research.

CLC number: R562.25 Document code: A Article ID: 1007-4368(2026)10-1584-09

References

【1】
【1】
 
 
Journal of Nanjing Medical University (Natural Sciences)
Pages 1584-1592

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Ding Z, Zhang Q. Research progress in nanotechnology for the diagnosis and treatment of bronchial asthma. Journal of Nanjing Medical University (Natural Sciences), 2026, 46(10): 1584-1592. https://doi.org/10.7655/NYDXBNSN260628

5

Views

0

Downloads

0

Crossref

Received: 19 May 2026
Revised: 21 July 2026
Accepted: 22 July 2026
Published: 15 October 2026
© 2026 Editorial Board of Journal of Nanjing Medical University(Natural Sciences)

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).